These apparently opposite activities of osteopontin in gliomas may stem from the fact that glioma-derived osteopontin is proteolytically degraded and is secreted as short fragments devoid of the pro-inflammatory activity [68]. The gene discussed is SPP1; the disease is central nervous system cancer.